Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | NMS-01940153E |
Synonyms | |
Therapy Description |
NMS-01940153E inhibits MPS1, potentially leading to decreased tumor cell proliferation and antitumor activity (Eur J Cancer 174 (2022): S2). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
NMS-01940153E | NMS 01940153E|NMS01940153E | NMS-01940153E inhibits MPS1, potentially leading to decreased tumor cell proliferation and antitumor activity (Eur J Cancer 174 (2022): S2). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05630937 | Phase Ib/II | NMS-01940153E | Study on Safety and Efficacy of NMS-01940153E in Adult Patients With Unresectable Hepatocellular Carcinoma Unresectable Hepatocellular Carcinoma (HCC) Previously Treated With Systemic Therapy | Completed | USA | ITA | ESP | 0 |